Form 483

Future Foam, Inc. Form 483, 2021-10-18

FDA issued a Form 483 to Future Foam, Inc. on 2021-10-18 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Future Foam, Inc. · San Clemente, United States · Issued October 18, 2021

Overview

  • 5 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Oct 2021
21 CFR 211.180(e)

Records reviewed annually

Cited by Khoa Nathan V Tran

18 Oct 2021
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Khoa Nathan V Tran

18 Oct 2021
21 CFR 211.192

Quality control unit review of records

Cited by Khoa Nathan V Tran

18 Oct 2021
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Khoa Nathan V Tran

18 Oct 2021
21 CFR 211.84(d)(2)

Component written specification

Cited by Khoa Nathan V Tran

Inspected site

FFFuture Foam, Inc.San Clemente, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere